Gulf War Syndrome
23
8
8
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.7%
2 terminated out of 23 trials
81.8%
-4.7% vs benchmark
9%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (23)
Coenzyme Q10 for Gulf War Illness: A Replication Study
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
Clinical Evaluation of Montelukast in Veterans With Gulf War Illness
Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)
Validating Gulf War Illness Blood Biomarkers
GWICTIC: NAC Mechanistic Study in Gulf War Veterans
Transcranial Direct Current Stimulation for Pain Treatment in Gulf War Illness.
Assessing Neuroinflammation in GWI Using MRS
Confirmation of Diet as a Treatment for Gulf War Illness
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
Mitochondrial Cocktail for Gulf War Illness
Ketamine in Veterans With Gulf War Illness
Glutamate Neuro-Excitotoxicity in GWI
Glutathione vs. Curcumin Clinical Trial
Alleviating Headache and Pain in GWI With Neuronavigation Guided rTMS
START & STOPP in GWI
Telemedicine Treatment for Veterans With Gulf War Illness
Mechanisms of Mitochondrial Defects in Gulf War Syndrome